TDACW (Translational Development Acquisition) EBIT : $-0.55 Mil (TTM As of Sep. 2024)

View and export this data going back to 2025. Start your Free Trial

What is Translational Development Acquisition EBIT?

Translational Development Acquisition's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2024 was $-0.06 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.55 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Translational Development Acquisition's annualized ROC % for the quarter that ended in Sep. 2024 was -9.65%. Translational Development Acquisition's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Translational Development Acquisition EBIT Historical Data

The historical data trend for Translational Development Acquisition's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Translational Development Acquisition EBIT Chart

Translational Development Acquisition Annual Data

Trend

Dec22

Dec23

Dec24

EBIT

-0.49

Translational Development Acquisition Semi-Annual Data
	May22	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
EBIT	Get a 7-Day Free Trial			-	-0.48	-	-0.06	-

Competitive Comparison of Translational Development Acquisition's EBIT

For the Shell Companies subindustry, Translational Development Acquisition's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Translational Development Acquisition's EV-to-EBIT Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Translational Development Acquisition's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Translational Development Acquisition's EV-to-EBIT falls into.

Translational Development Acquisition EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.55 Mil.

Translational Development Acquisition (NAS:TDACW) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Translational Development Acquisition's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

	ROC % (Q: Sep. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2024 )	+	Invested Capital (Q: Sep. 2024 ))	/ count )
=	-0.061 * ( 1 - 0% )	/	( (0.436	+	0.828)	/ 2 )
=	-0.061	/	0.632
=	-9.65 %

where

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.073	-	0.146	-	( 0.072	-	max(0, 0.582	-	0.073	+	0.072	))
=	0.436

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.394	-	0.306	-	( 0.224	-	max(0, 0.964	-	0.224	+	0.224	))
=	0.828

Note: The Operating Income data used here is one times the annual (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Translational Development Acquisition's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2024		Q: Sep. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.061	/	( ( (0 + max(-0.145, 0))	+	(0 + max(-0.305, 0)) )	/	2 )
=	-0.061	/	( ( 0	+	0 )	/	2 )
=	-0.061	/	0
=	%

where Working Capital is:

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.001)	-	(0.146	+	0	+	0)
=	-0.145

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0.306	+	0	+	-0.0010000000000001)
=	-0.305

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Translational Development Acquisition's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2024 )
	=	-0.545	/	0.000
	=	%

Translational Development Acquisition EBIT Related Terms

Thank you for viewing the detailed overview of Translational Development Acquisition's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.